BD Enters Pharma Market with New Generic Prefilled Injectables

Mar 28, 2013

PR Newswire

BD (Becton, Dickinson and Company) announced that the U.S. Food and Drug Administration has approved the first drug to be offered in the just-launched BD Simplist ready-to-administer, line of prefilled generic injectables. BD Simplist prefilled injectables will be commercialized and manufactured by BD Rx Inc., a wholly-owned subsidiary of BD. The first BD Simplist product BD Rx will launch is Diphenhydramine Hydrochloride Injection, USP, an injectable antihistamine.

Read the full story